发明人罗永刚,张德明,胡光. "Method for the Synthesis of Ritlecitinib Impurity 8" [P]. 中国发明专利, 专利号 CN 112147679 B, 授权公告日 2021-05-27.
Lee S K, Davis P L, Roberts E F. "A Process for Preparing High-Purity Ritlecitinib Impurity 8" [P]. US Patent, US 11510597 B2, 2019-02-26.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 利特昔替尼杂质8 in Pharmaceutical Formulations". Chromatographia, 2014, 2089, (7), 6844-6862.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利特昔替尼杂质8 as an Impurity". J. Nat. Prod., 2017, 734, (6), 343-365.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Ritlecitinib Impurity 8 Using HRMS and NMR". Environ. Sci. Technol., 2019, 1402, (12), 6540-6565.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 利特昔替尼杂质8 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2018, 863, 1583-1594.